Chelsie Miyao
Nurse Practitioner · Hilo, HINPI 1659857779
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,817 of the $2,112 with a category attached, or 86.0%. It is spread thinly across 27 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,469, 5.2 times the $282 reported in 2021.
Across 66 payments — averaging $32.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$264
- Johnson & Johnson$261
- Incyte Corporation$259
- AbbVie$176
- Seagen Inc.$145
- Boehringer Ingelheim$143
- plus $864 from 21 others
What the payments were for
- Food & beverage$1,81786%
- Education$29514%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 10 | $264 |
| Johnson & Johnson | 5 | $261 |
| Incyte Corporation | 4 | $259 |
| AbbVie | 5 | $176 |
| Seagen Inc. | 2 | $145 |
| Boehringer Ingelheim | 2 | $143 |
| Daiichi Sankyo Inc. | 4 | $99 |
| Pfizer | 5 | $97 |
| Novartis | 6 | $96 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $95 |
| Eisai Inc. | 3 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| Merck | 2 | $34 |
| Jazz Pharmaceuticals Inc. | 1 | $32 |
| Coherus Oncology, Inc. | 1 | $31 |
| Gilead(2 entities) | 2 | $27 |
| Rigel Pharmaceuticals, Inc. | 1 | $27 |
| Stemline Therapeutics Inc. | 1 | $25 |
| Tempus AI, Inc | 1 | $24 |
| AVEO Pharmaceuticals, Inc. | 1 | $24 |
| Blueprint Medicines Corporation | 1 | $24 |
| Sanofi | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Adaptive Biotechnologies Corporation | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
| EMD Serono, Inc. | 1 | $14 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,112 in reported general payments places this provider in the 85th percentile of 215 nurse practitioner providers in Hawaii.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acyclovir | 13 | $168 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Hilo
- Jonathan HollowayHilo$3K
- Mie FowlerHilo$2K
- Karen DavisHilo$840
- Kimi PrenticeEwa Beach$65K
- Ashley SpringerHonolulu$43K
- Sung JungHonolulu$29K
- Judy KoHonolulu$17K
- Joanna AgenaAiea$16K
- Rosemarie ForondaWailuku$15K
- Bryce MontalboHonolulu$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.